Un estudio muestra que las tasas de sensibilización a los alérgenos exteriores en Chicago aumentaron después del COVID-19

La gente ha escuchado durante años que el cambio climático está teniendo un impacto significativo en los patrones de vegetación de las plantas e influyendo en cómo se produce el polen y el moho. Un nuevo estudio que se presentará en la Reunión Científica Anual del Colegio Americano de Alergia, Asma e Inmunología (ACAAI) de este año en Boston mostró que, en Chicago, ha habido un aumento significativo en la sensibilización al polen y al moho en pacientes con alergias nasales.

Illinois virologist explains what’s in the new COVID-19 and flu vaccines, the best time to get them, and why we need them at all.

New vaccinations against influenza and the virus that causes COVID-19 are available and arriving at physician offices and pharmacies. University of Illinois Urbana-Champaign microbiology professor Chris Brooke is a virologist who studies respiratory viruses. He explains what’s in the new vaccines, the…

Mount Sinai Doctors to Present at ID Week 2024

Experts in infection prevention and control available for interview about research findings and other breaking health topics including the flu, COVID, HIV, mpox, West Nile, and vaccinations

Kids and the COVID-19 Vaccine: Your Questions Answered

While many parents have gotten their children vaccinated, some families have questions about the vaccine’s safety and efficacy. We spoke to several experts at Children’s Hospital Los Angeles, including Michael Smit, MD, MSPH, Hospital Epidemiologist and Medical Director of Infection Prevention and Control, and Marisa Glucoft, MPH, Vice President of Quality Improvement and Patient Safety, to answer some frequently asked questions.

Mount Sinai Opens State-of-the-Art Center for Patients With Complex Conditions Including Lyme Disease and Long COVID

The Cohen Center for Recovery From Complex Chronic Illnesses will also research new therapies for these conditions

COVID-19 recommendations for Fall 2024

Fall is here and with it, comes cold and flu season. With schools back in session and people gathering inside more, COVID will also be a player in this year’s circulating respiratory viruses.

Corewell Health’s infectious disease experts Dr. Russ Lampen and Dr. Nick Gilpin teamed up to answer the most frequently asked questions when it comes to this year’s COVID vaccine.

You can download an edited package HERE:
https://vimeo.com/1009923626/8089770e92?share=copy

Or, put together your own story using raw footage HERE:
https://vimeo.com/1010598326/33c7177fc1?share=copy

Thank you for your consideration. Please feel free to reach out with any questions.

History of COVID-19 Doubles Long-term Risk of Heart Attack, Stroke and Death

Cleveland: A history of COVID-19 can double the risk of heart attack, stroke or death according to new research led by Cleveland Clinic and the University of Southern California.
The study found that people with any type of COVID-19 infection were twice as likely to have a major cardiac event, such as heart attack, stroke or even death, for up to three years after diagnosis.

Penn Nursing Study Finds Link Between Nurse Work Environment Quality and COVID-19 Mortality Disparities

A new Penn Nursing Center for Health Outcomes and Policy Research (CHOPR) study – published in INQUIRY – has found a strong association between the quality of the nurse work environment and COVID-19 mortality rates among socially vulnerable Medicare beneficiaries. The study examined data from 238 acute care hospitals across New York and Illinois.

FAU Researchers Confront New U.S. and Global Challenges in Vaccinations of Adults

Over the past decade, decreasing vaccination rates now threaten the huge beneficial impacts of vaccinations in the U.S. and globally. Researchers discuss the multifactorial barriers including increasing vaccine hesitancy and new clinical and public health challenges in vaccinations of U.S. adults.

UC Irvine receives initial $33 million in federal support for vaccine research

Irvine, Calif., Oct. 3, 2024 — With an initial three-year, $33 million grant from the National Institute of Allergy and Infectious Diseases, the University of California, Irvine will lead a multi-institutional drive to create new vaccines as part of the Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness Network (ReVAMPP).

Mount Sinai Leaders Receive Prestigious Awards During the American College of Emergency Physicians 2024 Scientific Assembly (ACEP24)

CEO of the Mount Sinai Health System and Chair of the Emergency Department for Mount Sinai Queens will be honored for their contributions to health policy and diversity, inclusion, and health equity

Postpartum women filled more benzodiazepine prescriptions during pandemic

New research from the University of Georgia suggests the COVID-19 pandemic may have had an unexpected side effect for postpartum women: more benzodiazepine prescriptions. The new study found that the pandemic didn’t lead to increases in postpartum depression or anxiety diagnoses. But it did prompt a 15% increase in the number of privately insured new moms filling prescriptions for antianxiety medications like Valium, Xanax, Ativan and Klonopin.

COVID-19 lockdowns prematurely aged teenage brains, UW study shows

New research from the University of Washington found lockdowns during the COVID-19 pandemic resulted in unusually accelerated brain maturation in adolescents. This maturation was more pronounced in girls. When measured in terms of the number of years of accelerated brain development, the mean acceleration was 4.2 years in females and 1.4 years in males.

Analysis Shows How Unproven Therapeutics Were Portrayed in the Media During the Early Phase of COVID-19 Pandemic

A new study from researchers at Wake Forest University School of Medicine is shedding light on how scientific evidence and the uncertainty surrounding three unproven therapeutics were portrayed by the U.S. news media during the early days of the COVID-19 pandemic.

Growth from Adversity: How Older Adults Bounced Back from COVID-19 Pandemic

The study highlights the remarkable resilience of older adults (median age 86) during the COVID-19 pandemic. Disruptions to their routines led many to discover new hobbies like gardening and painting and explore virtual activities such as online yoga.

Good News for People with MS—COVID-19 Vaccine Not Tied to Relapse

People with multiple sclerosis (MS) have an increased risk of severe coronavirus infection, but there has been concern regarding potential relapse after vaccination. A new study finds that people with MS may not have a higher risk of relapse after COVID-19 vaccination. The study is published in the August 14, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Lung Surfactant Changes Implicated in COVID-19 Acute Respiratory Failure in Mice

Article title: Activation of alveolar epithelial ER stress by β-coronavirus infection disrupt surfactant homeostasis in mice: implications for COVID-19 respiratory failure Authors: Aditi Murthy, Luis R. Rodriguez, Thalia Dimopoulos, Sarah Bui, Swati Iyer, Katrina Chavez, Yaniv Tomer, Valsamma Abraham, Charlotte…